Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer

Anticancer Research

Volumn 32, Issue 6, 2012, Pages 2309-2314

  Kinugasa, Tetsushi ^a   Akagi, Yoshito ^a   Ochi, Takafumi ^a   Tanaka, Natsuki ^a   Kawahara, Akihiko ^a   Ishibashi, Yoshinobu ^a   Gotanda, Yukito ^a   Yamaguchi, Keizo ^a   Shiratuchi, Ichitarou ^a   Oka, Yousuke ^a   Kage, Masayoshi ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Claudin 1; Colorectal cancer; Hepatic metastasis

Indexed keywords

BETA CATENIN; CLAUDIN 1; UVOMORULIN; CADHERIN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR LOCALIZATION; UPREGULATION; BIOSYNTHESIS; COLORECTAL TUMOR; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84864532039     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ferlay J, Parkin DM and Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781, 2010.
2. Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T and Nishiyama Y: Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus. Cancer Gene Ther 14: 918-926, 2007.
3. Yamasaki M, Takemasa I, Komori T, Watanabe S, Sekimoto M, Doki Y, Matsubara K and Monden M: The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30: 129-138, 2007.
4. Chan KM, Chiang JM, Lee CF, Yu MC, Lee WC, Chen JS and Wang JY: Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol 9: 174, 2011.
5. Rees M, Tekkis PP, Welsh FK, O'Rourke T and John TG: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135, 2008.
6. Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, Mochizuki H and Yamamoto J: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46: S22-31, 2003.
7. Wei AC, Greig PD, Grant D, Taylor B, Langer B and Gallinger S: Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13: 668-676, 2006.
8. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA and Strasberg SM: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron-emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-447; discussion 447-450, 2004.
9. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ and Cameron JL: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766, 2002.
10. Tsukita S, Furuse M and Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293, 2001.
11. Itoh M, Furuse M, Morita K, Kubota K, Saitou M and Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363, 1999.
12. Hamazaki Y, Itoh M, Sasaki H, Furuse M and Tsukita S: Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277: 455-461, 2002.
13. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776, 2005.
14. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, Nabeshima K and Iwasaki H: Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27: 3729-3734, 2007.
15. Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K and Iwasaki H: Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 29: 851-857, 2009.
16. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST and So S: Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11: 551-556, 2005.
17. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A and Edwards BK: Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107: 1711-1742, 2006.
18. Peto J: Cancer epidemiology in the last century and the next decade. Nature 411: 390-395, 2001.
19. Tobioka H, Isomura H, Kokai Y and Sawada N: Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 198: 207-212, 2002.
20. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus 7th Edition Tokyo, Japan: Kanehara Shuppan 2006.
21. Kinugasa T, Sakaguchi T, Gu X and Reinecker HC: Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011, 2000.
22. Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ and Weeraratna AT: Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 26: 3846-3856, 2007.
23. Oku N, Sasabe E, Ueta E, Yamamoto T and Osaki T: Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 66: 5251-5257, 2006.
24. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M and Sato H: Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 276: 28204-28211, 2001.
25. Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, Lee YC, Hong TM and Yang PC: Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med 179: 123-133, 2009.
26. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
27. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y and Furukawa Y: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12: 469-476, 2001.
28. Hewitt KJ, Agarwal R and Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186, 2006.
29. Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46: 551-560, 2005.
30. Swisshelm K, Macek R and Kubbies M: Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57: 919-928, 2005.
31. Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606, 2005.
32. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G and Gress TM: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63: 6265-6271, 2003.
33. Resnick MB, Konkin T, Routhier J, Sabo E and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18: 511-518, 2005.
34. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD and Dhawan P: Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res 67: 1571-1579, 2007.
35. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M and Schulzke JD: Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun 314: 1001-1007, 2004.
36. Dorudi S, Sheffield JP, Poulsom R, Northover JM and Hart IR: Ecadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993.
37. Hollande F, Lee DJ, Choquet A, Roche S and Baldwin GS: Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. J Cell Sci 116: 1187-1197, 2003.